Implantica publishes Interim Report January - September 2025 (Q3)
PR Newswire —
VADUZ, Liechtenstein, Oct. 31, 2025 /PRNewswire/ -- RefluxStop® Nears FDA Approval - Strong Momentum Toward US Market Entry Significant events in the third quarter of 2025 Received positive feedback from the FDA on the final PMA Module 3 submission Expanded production by 10,000...
 
       
             
             
             
             
             
             
             
             
             
             
            